Medicxi IV LP

Overview

• HeadquartersY9¹
• Legal formOther
• Kind of organizationPrivate equity fund¹

See how the biggest companies compare on our leaderboards

Corporate structure

Medicxi IV LP sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• DIRECTOR OF THE MANAGING GENERAL PARTNERCHRISTOPHER H. PATTON named May 24, 2022²
• DIRECTOR OF THE MANAGING GENERAL PARTNERFRANCOIS H. CHESNAY named May 24, 2022²
• DIRECTOR OF THE MANAGING GENERAL PARTNERGIOVANNI H. PERICOLINI named May 24, 2022²

Filings

1 filings to the SEC since October 2021: 1 private raises. The latest 1:

1. May 24, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Medicxi IV LP has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• RAPT Therapeutics, Inc.SCHEDULE 13G Jan 6, 2025³

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. May 11, 2022Raised $195.4 million in a private offering of securities² Form D: 20 investors so far Form D